SEC Filing Details

Document Details

Filing Date
Nov 22, 2016
Document Date
Nov 22, 2016
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Bellerophon Therapeutics, Inc.
Issuer
BELLEROPHON THERAPEUTICS, INC.